Mattingly, Quincy |
Business Development Manager / Strategy Manager |
Elchrom Scientific AG |
Switzerland |
Mattner, Frank (Affiris 201502– Supervisory Board Member before CSO + Co-founder) |
Supervisory Board Member |
Affiris GmbH |
Austria |
Matuschek, Elke (Kompass PR 201204) |
Public Relations Manager / Investor Relations Manager |
Kompass PR Elke Matuschek |
Germany |
Matushansky, Igor (Hookipa Biotech 201802 CMO) |
Chief Medical Officer (CMO) |
Hookipa (Group) |
Austria |
Matyas, Viktor (Aignostics 202008 CEO) |
Chief Executive Officer (CEO) |
Aignostics GmbH |
Germany |
Matysiak, Stefan (febit 200705 VP + General Manager) |
General Manager (management) |
Hummingbird Diagnostics GmbH |
Germany |
Matz, Laura (Merck (DE) 202401 Chief Science & Technology Officer) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Merck (DE) (Group) |
Germany |
Matzen, Thomas J. C. |
n. a. |
BioAgency AG |
Germany |
Matzke, Alexandra (Amcure GmbH 201202– Managing Director + Co-founder) |
Managing Director |
Amcure GmbH |
Germany |
Matzko, Matthias (Imaging Service AG 200906 CEO) |
Chief Executive Officer (CEO) |
Imaging Service AG |
Germany |
Mauch, Herr (Intavis 200809) |
Sales Manager / Marketing Manager |
HB Technologies (Group) |
Germany |
Mauch, Klaus (Insilico Biotechnology 2004 became CEO before founder) |
Chief Executive Officer (CEO) |
Yokogawa (Group) |
Germany |
Mauch, Reiner (Schott 201310 Head of Business Development) |
Business Development Manager / Strategy Manager |
Schott (Group) |
Germany |
Maucher, Lukas (SHS 202205– CFO before one of Big Four auditing firms in Germany) |
Chief Financial Officer (CFO) |
SHS Capital (Group) |
Germany |
Maughan, Spencer (Finistere Partners 201502 Venture Partner before Venrock) |
Venture Partner |
Finistere Partners LLC (Finistere Ventures) |
United States (USA) |
Mauntz, Manfred (CMC Instruments GmbH 201304 Managing Director) |
Managing Director |
CMC Instruments GmbH Meß-, Regel- und Analysetechnik |
Germany |
Mauracher, Christoph (Sony 201207 Head of Sony DADC BioSciences) |
President/Director/Head Business Group/Unit/Division |
Stratec (Group) |
Austria |
Maurel, Loïc (Diaxonhit 201212– CEO before ExonHit President Management Board + France Biotech 201508 Board) |
Chief Executive Officer (CEO) |
Eurobio Scientific (Group) |
France |
Maurer, Hans H. (Saarland Univ 201003 Professor) |
Professor |
Saarland University (Universität des Saarlandes) |
Germany |
Maurer, Johannes (ImaGenes –200803–200904– Director Genomic Products + Marketing) |
Sales Manager / Marketing Manager |
Source BioScience (Group) |
Germany |
Maurer, Karl-Heinz (ABF 201101– BusDev AB Enzymes GmbH before Henkel KGaA Corporate Director Biotechnology) |
Business Development Manager / Strategy Manager |
ABF (Group) |
Germany |
Maus, Marcela V. (Harvard Univ 201708 Assistant Prof of Medicine at Harvard Medical + Director at MGHCC) |
Professor |
Harvard University |
United States (USA) |
Mauvernay, Rolland-Yves (Debiopharm 201301 President + Founder) |
President/Director/Head Business Group/Unit/Division |
Debiopharm (Group) |
Switzerland |
Mauvernay, Thierry (Debiopharm 201306 Board Member) |
Board member |
Debiopharm (Group) |
Switzerland |
Mavilio, Fulvio (French Myopathy Association 201512 Scientific Director at Généthon) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
French Myopathy Association (AFM) |
France |
May, Klaus J. W. (Genomatix 200411) |
Sales Manager / Marketing Manager |
Genomatix Software (Group) |
Germany |
May, Stephanie (Trophic Communications 201801 before MacDougall European Office) |
Public Relations Manager / Investor Relations Manager |
Trophic Communications GmbH |
Germany |
May, Tobias (Inscreenex 201204 Managing Director) |
Managing Director |
Inscreenex GmbH |
Germany |
May, Travis (Roivant Sciences 201709– CEO of Datavant before LiveRamp CEO) |
Chief Executive Officer (CEO) |
Roivant (Group) |
United States (USA) |
Mayer, Doris (AstraZeneca –201301 CFO at AstraZeneca GmbH LEFT 1/13) |
Chief Financial Officer (CFO) |
AstraZeneca (Group) |
Germany |
Mayer, Katja (Germany (govt) 201601 Project Manager GALS in Germany at German Entrepreneurship GmbH) |
business program (governmental) |
Start2 Group (Group) |
Germany |
Mayer, Manuel (Eppendorf 2008 Project Manager Development Hamburg) |
Research & Development Manager |
Eppendorf (Group) |
Germany |
Mayer, Matthias P. (Univ Heidelberg 201606 Professor at Centre for Molecular Biology (ZMBH)) |
n. a. |
University of Heidelberg (Ruperto Carola) |
Germany |
Mayer, Michael (TechnoStart 201107 Managing Director) |
Managing Director |
TechnoStart (Group) |
Germany |
Mayer, Robert (Medigene 201512– Senior Manager PR + IR before College Hill Life Sciences/Northbank Munich) |
Public Relations Manager / Investor Relations Manager |
Medigene (Group) |
Germany |
Maynard, Juliana (United Kingdom (govt) 202310 Director for NPIP + Head of Translational Imaging at MDC) |
President/Director/Head of Research Organisation/Unit |
United Kingdom (GB) (govt) |
United Kingdom (GB) |
Mayr, Andreas (Endress+Hauser 201606– Executive Board Member + Corp Director Marketing + Technology) |
Chief Technology/Technical Officer (CTO) |
Endress+Hauser (Group) |
Switzerland |
Mayr, Andreas (Therapy Invest Group 2012 founder) |
Company Founder |
Therapy Invest Group (Group) |
Germany |
Mayr-Harting, Lucia (Marinomed Biotech 202202 Public Relations) |
Public Relations Manager / Investor Relations Manager |
Marinomed Biotech AG (VSE: MARI) |
Austria |
Mayrhofer, Hans (MayLab 200703 Managing Director + Founder) |
Managing Director |
MayLab Analytical Instruments GmbH |
Austria |
Mayweg, Alexander (Alex) (Versant Ventures 202003 promoted to Managing Director joined 2016) |
Partner (venture partner) |
Versant Ventures |
Switzerland |
Mazey, Kara (MacDougall 201804) |
Public Relations Manager / Investor Relations Manager |
MacDougall Advisors Inc. |
United States (USA) |
Mazumdar-Shaw, Kiran (Biocon 201105 Managing Director + Founder) |
Managing Director |
Biocon (Group) |
India |
Mbow, Lamine (Boehringer 202301 Global Head of Cancer Immunology + Immuned Modulation) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
Germany |
McAdam, Michaela (Sartorius 201409 Marketing Communications Manager at TAP Biosystems) |
Sales Manager / Marketing Manager |
Sartorius (Group) |
United Kingdom (GB) |
McAllister, Andres (Debiopharm 201306 CSO Resesearch + Evaluation) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Debiopharm (Group) |
Switzerland |
McBean, Sandy (RainDance 201311 General Manager of Commercial Operations EMEA) |
Commercial Manager_o |
Bio-Rad (Group) |
France |
McBrearty, Joe (Canada (govt) 202310 CEO of Canadian Nuclear Laboratories) |
Chief Executive Officer (CEO) |
Canada (govt) |
Canada |
McCamish, Mark A. (Forty Seven 201705– CEO before Novartis/Sandoz + PDL Biopharma + Amgen + Abbott) |
Chief Executive Officer (CEO) |
Forty Seven Inc. |
United States (USA) |
McCann, Corey (Pear Therapeutics 201812 CEO) |
Chief Executive Officer (CEO) |
Pear Therapeutics Inc. (Nasdaq: PEAR) |
United States (USA) |
McCann, Joe (Point Biopharma 202310 CEO) |
Chief Executive Officer (CEO) |
Eli Lilly (Group) |
United States (USA) |
McCarthy, Laurence R. (Boehringer Mannheim –200708 President) |
n. a. |
Roche (Group) |
Germany |
McCarthy, Will (Genesis Therapeutics 202104– CBO before Generation Bio + Ignyta + Foundation Medicine + Haolzyme Tx) |
Chief Business Officer (CBO) |
Genesis Therapeutics Inc. |
United States (USA) |
McCaskill, John (Univ Bochum 200502) |
n. a. |
University of Bochum (Ruhr-Universität Bochum, RUB) |
Germany |
McCluskey, Marie (Qiagen 200909 Global Product Manager) |
Product Manager (personnel) |
Qiagen (Group) |
Germany |
McConnell, Wes (Ascend GCTx 202305 CFO before Bavarian Nordic) |
Chief Financial Officer (CFO) |
Ascend Gene and Cell Therapies (Ascend GCTx) (Group) |
United Kingdom (GB) |
McCourt, Tom (Ironwood 202305 CEO) |
Chief Executive Officer (CEO) |
Ironwood (Group) |
United States (USA) |
McCready, Travis (Massachusetts Life Sciences Center 201902 CEO) |
Chief Executive Officer (CEO) |
Massachusetts (govt region) |
United States (USA) |
McCullough, James (RenalytixAI 201803– CEO + Renwick Capital 201410– Managing Partner before Exosome Diagnostics) |
Chief Executive Officer (CEO) |
Renalytix AI (Group) |
United Kingdom (GB) |
McCully, James (Cellvie 202209 Co-Founder) |
Company Founder |
Cellvie (Group) |
Switzerland |
McDade, Mark (Qiming Venture Partners 201701– Partner before UCB + PDL Biopharma + Signature Bioscience + Corixa + BM) |
Partner (venture partner) |
Qiming (Group) |
United States (USA) |
McDermott, Charles (Charlie) (Primmune Therapeutics 202103 CEO formerly Kala Pharmaceuticals Inc. 201504 CBO) |
Chief Executive Officer (CEO) |
Primmune Therapeutics Inc. |
United States (USA) |
McDonnell, Patrick (Biotalys 202110– CBO based in US before BASF+ Bayer + Syngenta) |
Chief Business Officer (CBO) |
Biotalys (Group) |
Belgium |
McDowell, Andrew (EU (govt) 201812 VP at EIB) |
n. a. |
EU (govt) |
Luxembourg |
McErlane, Verna (BioOutsource 201309 Director of Sales) |
Sales Manager / Marketing Manager |
Sartorius (Group) |
United Kingdom (GB) |
McGarvey, David (Pharmaxis 201912 CFO + Company Sectretary) |
Chief Financial Officer (CFO) |
Pharmaxis Ltd. (ASX: PXS) |
Australia |
McGettigan, Gerry (AMP Biosimilars AG 201504 COO) |
Chief Operating Officer (COO) |
AMP Biosimilars AG |
Germany |
McGettrick, Aileen (Psyros Diagnostics 202201 Director + Co-Founder before Novartis NPTU/Vivacta) |
Board member, executive |
Prolight Diagnostics (Group) |
United Kingdom (GB) |
McGill, Stephen (Sequana Medical 201404– VP Sales + Marketing before Angiodynamics et al) |
Sales Manager / Marketing Manager |
Sequana Medical (Group) |
Switzerland |
McGinley, Michael (Phenomenex 201105 HPLC Product Manager) |
Product Manager (personnel) |
Danaher (Group) |
United States (USA) |
McGranahan, Nick (Sigsen Technologies 202407 CTO + Co-Founder) |
Chief Technology/Technical Officer (CTO) |
Agilent (Group) |
United States (USA) |
McGrath, Donnie (BMS 201511 VP Business Development) |
Business Development Manager / Strategy Manager |
Bristol Myers Squibb (BMS) (Group) |
United States (USA) |
McGregor, Laura (Schauenburg 201710– Product Marketing Manager at SepSolve before Product Marketing Manager at Markes) |
Sales Manager / Marketing Manager |
Schauenburg (Group) |
United Kingdom (GB) |
McGuinness, Ina (Rx Communications 201904) |
Public Relations Manager / Investor Relations Manager |
Rx Communications Group LLC (RxIR) |
United States (USA) |
McGuire, Mike (Roche 200610 VP anti-infectives) |
n. a. |
Roche (Group) |
Switzerland |
McIntire, Chris (ITT Corp 201009 President ITT Analytics) |
President/Director/Head Business Group/Unit/Division |
Xylem (Group) |
United States (USA) |
McIntosh, Barbara (Scienion 2018– President Scienion US before HyperTeknologies LLC 201610 CEO before BioDot) |
President/Director/Head Business Group/Unit/Division |
Bico (Group) |
United States (USA) |
McKernan, Kevin (Courtagen 201206 CSO before Agencourt CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Courtagen Life Sciences Inc. |
United States (USA) |
McKernan, R. Brian (Agencourt 200308 CEO) |
Chief Executive Officer (CEO) |
Courtagen Life Sciences Inc. |
United States (USA) |
McLaren, John (Dinaqor 202009– Chairman of Dynacor Ltd former British diplomat, investment banker + venture capitalist) |
Board member |
Dinaqor (Group) |
United Kingdom (GB) |
McLean, Andrew (Univ Oxford 201906 Head of Life Sciences 201712 Principal at Oxford Sciences Innovation) |
IP Manager |
Oxford Science Enterprises (Group) |
United Kingdom (GB) |
McMillan, Daniel (Danaher 201712 Business Development Manager at Sciex) |
n. a. |
Danaher (Group) |
United Kingdom (GB) |
McMullen, Mike (Agilent 201409– COO + designated CEO for 3/15 before SVP + President Chemical Analysis Group) |
Chief Operating Officer (COO) |
Agilent (Group) |
United States (USA) |
McNamara, Brian (GSK 201609– CEO of Consumer Healthcare division before Novartis + Procter & Gamble) |
Chief Executive Officer (CEO) |
GSK (Group) |
United Kingdom (GB) |
McNamara, Peter (Tectonic Therapeutic 202005– before Genomics Institute of Novartis Research Foundation since 2005) |
Research & Development Manager |
Tectonic Therapeutic Inc. |
United States (USA) |
McNamara, Phil (Bayer 202303 VP Corporate Communications at AskBio) |
Public Relations Manager / Investor Relations Manager |
Bayer (Group) |
United States (USA) |
McNeill, Jonathan (Forbion 202501– Partner in Boston Office before Dyne Therapeutics + Editas Medicine + BCG) |
Partner (venture partner) |
Forbion (Group) |
United States (USA) |
McWeeny, Kerri (Stilla Technologies 202311– General Manager for North America before Jumpcode Genomics + Illumina) |
General Manager (management) |
Stilla Technologies (Group) |
United States (USA) |
Meade, Jennifer (Hologic 202101 Division President Breast + Skeletal Health Solutions) |
President/Director/Head Business Group/Unit/Division |
Hologic (Group) |
United States (USA) |
Meadows-Smith, Marcus (AgraQuest 201207 CEO) |
Chief Executive Officer (CEO) |
Bayer (Group) |
United States (USA) |
Mechtersheimer, Thomas (Tom) (Neurocare Group 202405 CEO) |
Chief Executive Officer (CEO) |
Neurocare Group AG |
Germany |
Mechtler, Karl (Research Institute for Molecular Pathology IMP 201311 Head of Protein Chemistry Facility) |
Head Mass Spectrometry / NMR Laboratory (university / research institute) |
IMP (Compnay) |
|
Meckfessel, Julian (Allogenetics 202409) |
n. a. |
Allogenetics GmbH |
Germany |
Medeiros, Paul (Purdue Pharma 201708 SVP Corp + Business Develompent at Mundipharma) |
Business Development Manager / Strategy Manager |
Purdue Pharma (Group) |
United Kingdom (GB) |
Meder, Bernhard (M-Invest GmbH 2013 Managing Director) |
Managing Director |
M-Invest GmbH |
Germany |
Medina, Jan (InflaRx 202402– Head of Investor Relations before Olink Proteomics) |
Public Relations Manager / Investor Relations Manager |
InflaRx (Group) |
Netherlands |
Meek, David (Ferring 202001– CEO of FerGene before Ipsen + Baxalta + Endocyte + Novartis + JnJ) |
Chief Executive Officer (CEO) |
Ferring (Paulsen Foundation) (Group) |
United States (USA) |
Mégret, Dominique (Swisscom 201901 Head of Swisscom Ventures) |
President/Director/Head Business Group/Unit/Division |
Swisscom (Group) |
Switzerland |
Mehl, Konstantin (Kaia Health 202006 Managing Director) |
Managing Director |
Kaia Health (Group) |
Germany |
Mehler, Michael (AXA 201208 CEO of Riemser Pharma before Actelion + Novartis) |
Chief Executive Officer (CEO) |
Esteve (Group) |
Germany |